Tags Research


Preclinical and clinical assessment of cannabinoids

fb-square-english-spanish10/7/16--This article aims to review study results which evaluated effects of cannabinoids from plant, synthetic, and endogenous origins on cancer development in preclinical animal models and to examine the current standing of cannabinoids that are being tested in human cancer patients. Read

What do we know about marijuana’s medical benefits?

fb-square-english-spanish10/18/16--Steven Kinsey of West Virginia University and Divya Ramesh of University of Connecticut have no political position on cannabis legalization; however, they do study the cannabis plant and its related chemical compounds. According to both experts, there's not enough information about cannabis or its elements to judge how effective it is as a medicine, but say well-designed studies are the most effective way to understand what medical benefits cannabis may have. While research on cannabis or cannabinoids is difficult, it's necessary to get the facts in order. Read

2 marijuana stocks going in opposite directions

screen-shot-2016-10-31-at-11-05-29-am10/14/16--GW Pharmaceuticals and Insys Therapeutics, two publicly traded drugmakers that are researching marijuana medicine, are moving in opposite directions. While GW Pharmaceuticals' shares are on the upswing with shares more than doubling, a troubled past that includes investigations into Insys Therapeutics' marketing of the opioid pain-killer Subsys has caused its shares to crash more than 50%. Read

Why this marijuana stock crashed 18% in September

screen-shot-2016-10-20-at-10-12-56-am10/6/16--Insys Therapeutics shares fell 17.9% in September, and they're down 54% since September 2015. Growing concern over opioid abuse has caused Subsys sales to drop significantly this year. The company hopes the FDA's approval of its oral version of the marijuana-based drug Marinol in July can offset some of Subsys' sales decline. Read

Can marijuana really reduce pot bellies and obesity?

screen-shot-2016-10-02-at-7-55-23-pm9/19/16--According to a recent study, marijuana users may be more likely to have a lower body mass index (BMI) or less likely to be obese or overweight than non-users. University of Miami researchers determined that women who use marijuana daily had on average BMIs approximately 3.1% lower than that of non-users. Read

Opiate addiction experts turn to marijuana as safer alternative to pain relief

issues that are currently treated primarily via opiates. Dr. Daniele Piomelli, a professor of anatomy and neurobiology at the UC Irvine School of Medicine is calling the use of marijuana in pain management an encouraging turning point in the opiate crisis. Read